Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Sep;99(9):3373-81.
doi: 10.1210/jc.2014-1714. Epub 2014 Jun 2.

25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype

Affiliations
Clinical Trial

25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype

K S Jones et al. J Clin Endocrinol Metab. 2014 Sep.

Abstract

Context: There is uncertainty over the equivalence of vitamins D2 and D3 to maintain plasma 25-hydroxyvitamin D (25(OH)D).

Objective: The objective of the study was to compare the plasma half-lives of 25(OH)D2 and 25(OH)D3 in two distinct populations with different dietary calcium intake and 25(OH)D status.

Participants: Healthy men (aged 24 and 39 y), resident in The Gambia (n = 18) or the United Kingdom (n = 18) participated in the study.

Interventions: The intervention included an oral tracer dose of deuterated-25(OH)D2 and deuterated-25(OH)D3 (both 40 nmol). Blood samples were collected over 33 days.

Main outcome measures: 25(OH)D2 and 25(OH)D3 plasma half-lives, concentrations of 25(OH)D, and vitamin D binding protein (DBP) and DBP genotypes were measured.

Results: 25(OH)D2 half-life [mean (SD)] [13.9 (2.6) d] was shorter than 25(OH)D3 half-life [15.1 (3.1) d; P = .001] for countries combined, and in Gambians [12.8 (2.3) d vs 14.7 (3.5) d; P < .001], but not in the United Kingdom [15.1 (2.4) d vs 15.6 (2.5) d; P = .3]. 25(OH)D concentration was 69 (13) and 29 (11) nmol/L (P < .0001), and the DBP concentration was 259 (33) and 269 (23) mg/L (P = .4) in The Gambia and United Kingdom, respectively. Half-lives were positively associated with plasma DBP concentration for countries combined [25(OH)D2 half-life: regression coefficient (SE) 0.03 (0.01) d per 1 mg/L DBP, P = .03; 25(OH)D3 half-life: 0.04 (0.02) d, P = .02] and in Gambians [25(OH)D2 half-life: 0.04 (0.01) d; P = .02; 25(OH)D3 half-life: 0.06 (0.02) d, P = .01] but not in UK participants. The DBP concentration × country interactions were not significant. DBP Gc1f/1f homozygotes had shorter 25(OH)D2 half-lives compared with other combined genotypes (P = .007) after correction for country.

Conclusions: 25(OH)D2 half-life was shorter than 25(OH)D3 half-life, and half-lives were affected by DBP concentration and genotype. The stable isotope 25(OH)D half-life measurements provide a novel tool to investigate vitamin D metabolism and vitamin D expenditure and aid in the assessment of vitamin D requirements.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mean, SD, and individual values for the half-lives of 25(OH)D2 (▴) and 25(OH)D3 (●) for countries combined [18 Gambian (solid symbols) and 18 UK (open symbols) participants] (A) and the countries separated (B). Differences between the half-lives of 25(OH)D2 and 25(OH)D3 and country differences are displayed as P values.
Figure 2.
Figure 2.
Country-specific relationships between the half-lives and total 25(OH)D, DBP, and b25(OH)D concentrations for 25(OH)D2 (▴, Gambia; ▵, UK) and 25(OH)D3 (●, Gambia; ○, UK) in 18 Gambian and 18 UK participants, and Gc-b25(OH)D in 16 Gambian and 12 UK participants. The charts show individual values and country-specific regression lines. Regression line statistics are shown in Table 2.

References

    1. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Acadamies Press; 2011 - PubMed
    1. Holick MF, Biancuzzo RM, Chen TC, et al. . Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93:677–681 - PMC - PubMed
    1. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab. 2011;96:E447–E452 - PubMed
    1. Binkley N, Gemar D, Engelke J, et al. . Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50 000 IU monthly in older adults. J Clin Endocrinol Metab. 2011;96:981–988 - PMC - PubMed
    1. Demetriou ET, Travison TG, Holick MF. Effect of treatment with 50 000 IU vitamin D2 every other week on serum 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, and total 25-hydroxyvitamin D in a clinical setting. Endocr Pract. 2012;18:399–402 - PubMed

Publication types

MeSH terms